Eli Lilly Hid Cymbalta Risks, Jury Told As Bellwether Opens

By Daniel Siegal ( August 4, 2015, 9:56 PM EDT) -- Counsel for a woman alleging Eli Lilly & Co. concealed the withdrawal risks of its antidepressant Cymbalta told a California federal jury during opening statements in the bellwether trial Tuesday that the drugmaker's own study revealed almost half of patients who stopped taking the drug risked withdrawal symptoms....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!